Activin and Inhibin

Fedovapagon (VA106483) is a selective and orally active Vasotocin V2 receptor (V2R) agonist with an EC 50 of 24 nM. Fedovapagon can be used in the research of nocturiaIn VivoFedovapagon (1 mg/kg, oral administration) inhibits urine output with 81%

Fenbendazole.

Fenbendazole.

Fenbendazole.

Fenbendazole.

Fenhexamid.

Fenhexamid.

Feniralstat (compound 30), a pyrazole derivative, is a potent kallikrein inhibitor with an IC 50 of 6.7 nM for Human plasma kallikrein (pKal). Feniralstat has no inhibition on Human KLKl, Human FXIa, Human Factor Xlla (all IC 50 &gt:40

Feniralstat (compound 30), a pyrazole derivative, is a potent kallikrein inhibitor with an IC 50 of 6.7 nM for Human plasma kallikrein (pKal). Feniralstat has no inhibition on Human KLKl, Human FXIa, Human Factor Xlla (all IC 50 &gt:40

Fenretinide (4-HPR) is a synthetic retinoid deriverative. 4-HBR is shown to exhibit binding to the retinoic acid receptors (RAR) at concentrations necessary to induce cell death. An agonist displaying activity at retinoid receptors.

Fenretinide (4-HPR) is a synthetic retinoid deriverative. 4-HBR is shown to exhibit binding to the retinoic acid receptors (RAR) at concentrations necessary to induce cell death. An agonist displaying activity at retinoid receptors.

Fenretinide (4-HPR) is a synthetic retinoid deriverative. 4-HBR is shown to exhibit binding to the retinoic acid receptors (RAR) at concentrations necessary to induce cell death. An agonist displaying activity at retinoid receptors.